Physician profile
Peter S Johnson
NPI 1003872607
$3,516.55
in general payments reported to CMS, 2019-2025
17 companies · $615 in 2025
The $615 reported for 2025 was more than what 87% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $245 · 2022: $512 · 2023: $829 · 2024: $632 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,915 · Education: $137 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,914.97 |
| Education | $137.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $619.80 | 2019-2024 | |
| Pacira Pharmaceuticals Incorporated | $373.11 | 2020-2023 | Iovera |
| Heron Therapeutics, INC. | $343.64 | 2022-2025 | Zynrelef, Aponvie |
| Csl Behring | $341.97 | 2020-2025 | Kcentra |
| Kerecis Limited | $250.00 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $166.63 | 2022 | |
| Davol INC. | $164.65 | 2023-2024 | Phasix Mesh |
| Acumed LLC | $157.93 | 2023 | Ribloc |
| Cumberland Pharmaceuticals, INC. | $149.11 | 2023 | Caldolor |
| Aroa Biosurgery Incorporated | $137.99 | 2023 | |
| Eagle Pharmaceuticals, INC. | $127.51 | 2024 | |
| Baxter Healthcare | $125.00 | 2019 | |
| Acell, INC. | $125.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.24 | 2025 | Gattex |
| Kci USA, INC. | $113.02 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $103.13 | 2019 | |
| Medline Industries LP | $99.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.